Image is not available
Image is not available
Image is not available
previous arrow
next arrow

Yourgene Health’s quality management system has been assessed and approved as applicable to the design, development and manufacture of in vitro diagnostic reagents and associated software for non-invasive assessment of genetic abnormalities. Yourgene is ISO 13485:2016 certified and operates to a quality management system which is in compliance with the EC In Vitro Diagnostic Directive (98/79/EC).

The Company has been audited against the requirements of Annex IV of the In Vitro Diagnostic Directive (98/79/EC) and recommended by Notified Body BSI NL for an EC certificate demonstrating full quality assurance system approval.

The manufacturers of all in vitro diagnostic products for sale in Europe must ensure that their products meet the requirements laid out in the European In Vitro Diagnostic Directive (98/79/EC). For the purpose of affixing a CE mark, the IONA® test has been developed to meet the ‘essential requirements’ specified in Annex I of the Directive and has followed the conformity assessment route of full quality assurance system certification and review of the design dossier by a Notified Body in line with the IONA® test’s classification under Annex II list B of the Directive. The IONA® test received its CE mark in February 2015.

Yourgene Laboratory Services in Manchester is Care Quality Commission (CQC) registered. CQC is an independent regulator of health and social care in England. Yourgene Laboratory Services in Taipei is ISO 17025 accredited and TAF (Taiwan Accreditation Foundation No: 2738) certified.

ISO13485:2016 Certificate.pdf

CE Certificate BSI.pdf

PDF of ISO17025 Certificate

TAF logo

Group of business people in a meeting

Test Tube